H. Lee Moffitt Cancer Center And Research Institute
Clinical trials sponsored by H. Lee Moffitt Cancer Center And Research Institute, explained in plain language.
-
New hope for CLL patients: umbralisib shows promise in early trial
Disease control TerminatedThis study tested the experimental drug umbralisib in 12 people with chronic lymphocytic leukemia (CLL) who had not yet received treatment. The goal was to see how well the drug shrank or controlled the cancer and to check for side effects. The study was stopped early, but result…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Experimental AML drug trial halted early: what we know
Disease control TerminatedThis study tested a drug called Minnelide in adults with acute myeloid leukemia (AML) that either returned after treatment or did not respond to standard therapy. The goal was to find the safest dose and check for side effects. The trial was stopped early, and results are limited…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC